Voya Investment Management LLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 35,585 shares of the company's stock, valued at approximately $1,717,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in TEM. Cherry Tree Wealth Management LLC purchased a new stake in Tempus AI in the first quarter valued at about $31,000. University of Texas Texas AM Investment Management Co. purchased a new stake in Tempus AI in the first quarter valued at about $33,000. Continuum Advisory LLC purchased a new stake in Tempus AI in the first quarter valued at about $39,000. Bartlett & CO. Wealth Management LLC raised its stake in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after buying an additional 400 shares during the last quarter. Finally, Nemes Rush Group LLC purchased a new stake in Tempus AI in the first quarter valued at about $39,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.
Tempus AI Stock Down 2.7%
Shares of TEM stock opened at $85.87 on Tuesday. The stock has a 50 day moving average of $71.02 and a 200 day moving average of $61.08. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The stock has a market cap of $14.92 billion, a P/E ratio of -72.16 and a beta of 5.07. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $97.79.
Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI's quarterly revenue was up 89.5% on a year-over-year basis. During the same period last year, the business earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.
Wall Street Analysts Forecast Growth
TEM has been the subject of a number of research analyst reports. Bank of America increased their price target on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. HC Wainwright raised their price objective on Tempus AI from $90.00 to $98.00 and gave the stock a "buy" rating in a research note on Friday, September 12th. Piper Sandler restated a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. BTIG Research raised their price objective on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research note on Wednesday, August 20th. Finally, Morgan Stanley raised their price objective on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 12th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $70.17.
Get Our Latest Stock Report on Tempus AI
Insider Activity at Tempus AI
In related news, COO Ryan Fukushima sold 17,460 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the completion of the transaction, the chief operating officer directly owned 839,180 shares in the company, valued at approximately $62,644,787. This trade represents a 2.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Andrew Polovin sold 5,398 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $402,960.70. Following the transaction, the executive vice president owned 132,056 shares of the company's stock, valued at approximately $9,857,980.40. This represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 601,787 shares of company stock valued at $42,492,268 in the last 90 days. 26.27% of the stock is currently owned by corporate insiders.
Tempus AI Company Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.